Last updated on March 2019

Management of Symptomatic Advanced Pancreatic Adenocarcinoma

Brief description of study

This study assessed the feasibility and effects of an early integrative supportive care program in patient with Advanced pancreatic adenocarcinoma (aPDAC).

Detailed Study Description

Two-step cohort study:

  • Step 1 : A 14-day integrative supportive care program initiated as early as the clinical suspicion of aPDAC.

According to the investigator's assessment of patient needs, this integrative supportive care program will include:

  • management of pain
  • nutritional support
  • pathologic diagnosis (endoscopy guides or percutaneous biopsies or ascitis cytology)
  • diagnostic computed imaging
  • endoscopic stenting of the bile duct and/or duodenum
    • Step 2 : Follow up after the integrative supportive care program. According to their Eastern Cooperative Oncology Group Performance Status(ECOG PS) and/or chemotherapy
  • Group 1 : Patient becoming eligible for treatment with FOLFIRINOX or nab-paclitaxel + gemcitabine and / or clinical trial
  • Group 2 :Patient at the end of the 14-day program (Step 1) remaining with either :

a - Persisting ECOG PS 2

b - Clinico-biological features that make them ineligible to receive the FOLFIRINOX or nab-paclitaxel + gemcitabine regimens

c - Patient ineligible to other therapeutic clinical trial

Clinical Study Identifier: NCT02979483

Find a site near you

Start Over